AI assistant
Ion Beam Applications, SA Major Shareholding Notification 2022
3960_mrq_2022-04-22_f50f2adf-55eb-424c-b6eb-9453c19fa70d.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
IBA – TRANSPARENCY NOTIFICATION
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)
Louvain-la-Neuve, Belgium, April 22, 2022
Summary of the notification
IBA (Ion Beam Application), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on April 11, 2022.
In its notification, Norges Bank has notified, that following the acquisition or disposal of voting securities or voting rights, its total holding in Norges Bank has crossed upwards the 2% threshold.
Content of the notification
- Reason for the notification: Acquisition or disposal of voting securities or voting rights
- Notification by : A person that notifies alone
- Persons subject to the notification requirement: Norges Bank, Bankplassen 2, PO Box 1179 Sentrum, 0107 Oslo, Norway
- Date on which the threshold is crossed: 07/04/2022
- Threshold crossed (in %): 2%
- Denominator: 38.339.545
- Details of the notification: (excerpt from the notification form received)
| A) Voting rights | Previous notification | After the transaction | |||||
|---|---|---|---|---|---|---|---|
| # of voting rights | # of voting rights | % of voting rights | |||||
| Holders of voting rights | Linked to securities | Not linked to the securities |
Linked to securities | Not linked to the securities |
|||
| Norges Bank | 668,964 | 795,379 | 0 | 2.07% | 0.00% | ||
| TOTAL | 795,379 | 0 | 2.07% | 0.00% |
Press release
| B) Equivalent financial instruments | After the transaction | |||||||
|---|---|---|---|---|---|---|---|---|
| Holders of equivalent financial instruments |
Type of financial instrument | Expiration date | Exercise period or date |
# of voting rights that may be acquired if the instrument is exercised |
% of voting rights | Settlement | ||
| TOTAL | 0 | 0.00% | ||||||
| P The totals will be updated once you have clicked on |
||||||||
| TOTAL (A & B) | # of voting rights | % of voting rights | ||||||
| CALCULATE | 795,379 | 2.07% |
• Full chain of controlled undertakings through which the holding is effectively held
Norges Bank is the central bank of Norway. As part of its central bank activities, Norges Bank manages Norway's foreign exchange reserves and is responsible for management of the Norwegian Government Pension Fund Global (GPFG). The formal responsibility for management of the GPFG is placed with the Ministry of Finance, but is delegated to Norges Bank. All investments are executed by Norges Bank acting as principal and all holdings are registered in the name of Norges Bank.
For further information, please contact:
IBA
Valérie Van Impe Paralegal [email protected]
About IBA
IBA (Ion Beam Applications) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA's proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.
IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com
Press release
IBA | Ion Beam Applications Chemin du Cyclotron, 3 | 1348 Louvain-la-Neuve | Belgium | RPM Brabant Wallon | VAT BE0428.750.985 T +32 10 47 58 11 | F +32 10 47 58 10 | [email protected] | iba-worldwide.com
